FDA declines to approve nasal spray alternative to EpiPen

In a surprise to its makers, a nasal spray intended to be an alternative to the EpiPen was sent back by the FDA, the company announced.

Related Keywords

United States ,Americans ,Richard Lowenthal ,Pharmaceuticals On ,Asthma Network ,European Medicines Agency ,Advisory Committee ,Drug Administration ,Allergy Drugs Advisory Committee ,Committee For Medicinal Products Human ,Medicinal Products ,Human Use ,